Want to see JBIO full AI Analyst Report?
Total Valuation
Jade Biosciences has a market cap or net worth of $1.57B. The enterprise value is $895.97.
Market Cap$1.57B
Enterprise Value$895.97
Share Statistics
Jade Biosciences has 63,597,385 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding63,597,385
Owned by Insiders8.01%
Owned by Institutions54.80%
Financial Efficiency
Jade Biosciences’s return on equity (ROE) is -0.38 and return on invested capital (ROIC) is -34.07%.
Return on Equity (ROE)-0.38
Return on Assets (ROA)-0.36
Return on Invested Capital (ROIC)-34.07%
Return on Capital Employed (ROCE)-0.34
Revenue Per Employee0.00
Profits Per Employee-2.32M
Employee Count55
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Jade Biosciences is ―. Jade Biosciences’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.00
PB Ratio1.46
Price to Fair Value1.46
Price to FCF-5.10
Price to Operating Cash Flow-12.21
PEG Ratio0.04
Income Statement
In the last 12 months, Jade Biosciences had revenue of 0.00 and earned -127.41M in profits. Earnings per share was -4.06.
Revenue0.00
Gross Profit0.00
Operating Income-113.54M
Pretax Income-127.35M
Net Income-127.41M
EBITDA-127.33M
Earnings Per Share (EPS)-4.06
Cash Flow
In the last 12 months, operating cash flow was -123.51M and capital expenditures -60.00K, giving a free cash flow of -123.57M billion.
Operating Cash Flow-123.51M
Free Cash Flow-123.57M
Free Cash Flow per Share-1.94
Dividends & Yields
Jade Biosciences pays an annual dividend of $2.4, resulting in a dividend yield of ―
Dividend Per Share$2.4
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.20
52-Week Price Change229.47%
50-Day Moving Average20.16
200-Day Moving Average17.14
Relative Strength Index (RSI)70.11
Average Volume (3m)1.18M
Important Dates
Jade Biosciences upcoming earnings date is Nov 16, 2026, Before Open (Confirmed).
Last Earnings DateAug 10, 2026
Next Earnings DateNov 16, 2026
Ex-Dividend Date―
Financial Position
Jade Biosciences as a current ratio of 20.33, with Debt / Equity ratio of 0.14%
Current Ratio20.33
Quick Ratio20.33
Debt to Market Cap0.00
Net Debt to EBITDA0.69
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Jade Biosciences has paid 58.00K in taxes.
Income Tax58.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Jade Biosciences EV to EBITDA ratio is -3.11, with an EV/FCF ratio of -4.18.
EV to Sales0.00
EV to EBITDA-3.11
EV to Free Cash Flow-4.18
EV to Operating Cash Flow-4.18
Balance Sheet
Jade Biosciences has $461.20M in cash and marketable securities with $628.00K in debt, giving a net cash position of $460.58M billion.
Cash & Marketable Securities$461.20M
Total Debt$628.00K
Net Cash$460.58M
Net Cash Per Share$7.24
Tangible Book Value Per Share$10.60
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Jade Biosciences is $50.13, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$50.13
Price Target Upside149.63% Upside
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast―
EPS Growth Forecast91.41%